Skip to main content

Table 1 Basic characteristic of the patients with primary hepatic malignant vascular tumor

From: Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features

Variables PHA EHE MHP IHE
No. of patients 11 15 3 13
Gender
 Male 4 (36%) 2 (13%) 1 (33%) 6 (46%)
 Female 7 (64%) 13 (87%) 2 (67%) 7 (54%)
Age, median, y (range) 52 (39–74) y 41 (29–69) y 47 (32–55)y 3 (0.2–24)m
Clinical symptom
 Upper abdominal pain 4 (36%) 4 (27%) 2 (67%) 0
 Loss of appetite and weight 4 (36%) 1 (7%) 0 0
 Fever 1 (9%) 1 (7%) 0 2 (15%)
 Jaundice and diarrhea 1 (9%) 0 0 3 (23%)
 Growth retardation 0 0 0 1 (8%)
 Thrombocytopenia 0 0 0 1 (8%)
 Abdominal mass 0 0 0 6 (46%)
 Asymptomatic patient 1 (9%) 3 (20%) 1 (33%) 0
Medical history
 Hepatitis-B/ Cirrhosis 3 (27%) 1 (7%) 0 0
 CHD 2 (18%) 1 (7%) 0 0
 Hypertension 4 (36%) 3 (20%) 0 0
 Diabetes 3 (27%) 3 (20%) 0 0
Treatment strategy
 Hepatectomy 5 (45%) 15 (100%) 2 (67%) 13 (100%)
 TACE 1 (9%) 0 0 0
 Radiofrequency ablation 1 (9%) 0 0 0
 Chemotherapy 2 (18%) 0 0 0
 Antiangiogenic therapy 1 (9%) 0 0 0
 Postoperative chemotherapy 1 (9%) 0 1 (33%) 0
Median survival time, months 15 88 23 96
  1. Note: PHA Primary hepatic angiosarcoma; EHE Epithelioid hemangioendothelioma; MHP Malignant hemangiopericytoma; IHE Infantile hemangioendothelioma; CHD Coronary heart disease; TACE Transarterial chemoembolization